DDIT3 and central nervous system cancer: In this regard, other studies presented that DR5 up-regulating upon combination therapy with TRAIL and paxilline was responsible for sensitizing TRAIL-resistance glioma cell to TRAIL-induced apoptosis mediated by a C/EBP homologous protein (CHOP)/GADD153-arbitrated process (Figure 5) (82).